Drug intelligence / Profile preview

perflutren

Development stage
Approved
Lead developer
Scott Medical Products
Modality
Small Molecules
Administration
Intravitreal, Inhalation
01

Overview

**Perflutren**, also called perfluoropropane or octafluoropropane, is an inert fluorinated gas with molecular formula C3F8. In ophthalmology, intravitreal perfluoropropane forms a long-acting expandable gas bubble that provides physical tamponade: it apposes a detached retina to the retinal pigment epithelium and limits fluid movement through retinal breaks while healing occurs. FDA-approved UNIPURE C3F8 ophthalmic-gas delivery systems are indicated for treatment of uncomplicated retinal detachment; the gas bubble typically dissipates over approximately 6 to 8 weeks. Perflutren is also the gas constituent of certain ultrasound contrast-microsphere products, but those lipid- or albumin-microsphere formulations are distinct combination products and are not synonymous with neat perfluoropropane gas. ([fda.gov](https://www.fda.gov/medical-devices/recently-approved-devices/unipure-c3f8-ophthalmic-gas-unifeye-gas-delivery-system-unipexy-gas-delivery-system-p220030))

Brand names
ISPAN C3F8UNIPURE C3F8 Ophthalmic Gas
Other names
perfluoropropaneoctafluoropropaneC3F8C-3F8C 3F81,1,1,2,2,3,3,3-octafluoropropanepropane octafluoro

Beyond the preview

Go deeper on perflutren.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on perflutren.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call